As chief business officer, Jonathan Andrus leads Clinical Ink’s solution management and commercial teams to help sponsors and CROs better leverage eSource, eCOA, and ePRO data. With more than 25 years of experience, Mr. Andrus brings extensive expertise developing eClinical services that integrate data and technology to help life science companies optimize study execution. At Clinical Ink, Mr. Andrus is responsible for P&L across Clinical Ink’s products and services, and he is also focused on building relationships and forging strategic partnerships with sponsors, CROs, regulatory bodies, and clinical research professionals.

Within SCDM, Jonathan, over the past 14 years on the board:

• Served as SCDM Chair - 2008 and 2013
• Serves as regulatory liaison and annual regulatory town hall host
• Serves as SCDM Treasurer and Executive Committee Member

Demetris is currently VP and Global Head of Data Monitoring and Management at Pfizer. Demetris started his career as a Laboratory Scientist in 1991 and transitioned into the Clinical Development space where he held roles of increasing responsibilities in Trial Management and Monitoring and led the implementation of the company’s first Clinical Trial Management system. In 2000, Demetris was a member and eventually the leader of the team which executed the industry’s first Tech- Transfer of a web based EDC system. He eventually led the Data Management and Standards organization and continued on to Merck & Co. following the merger in 2009. Subsequently Demetris was Vice President of Data Management at Novartis AG from 2014 to 2017. Since 2017 Demetris leads Pfizer’s Data Management and Risk Based Monitoring line functions in a new transformation; developing and transitioning into an internal operating model across multiple geographic sites in support of Pfizer’s portfolio. He also leads the Data and Automation work stream as part of Pfizer’s Development-wide transformation effort. He currently serves on multiple Boards, including SCDM’s Advisory Board, has served on the Board of Trustees and was the 2016 Chair.

Prasanna Rao is an AI practitioner and Industry Thought Leader whose current role is the Head of Artificial Intelligence and Data Science for Data Management and Monitoring at Pfizer. He has over 25 years of experience in Information technology and Analytics, with 10 years in Healthcare and Life Sciences. He has implemented several AI projects in the last 8 years including projects with IBM Watson Health, as a Watson Solution Architect. His role at Pfizer is to analyze Clinical Development use cases, carefully evaluate various AI/ML techniques, conduct hackathons, and implement AI & automation solutions to deliver business value.

An experienced data manager leader Ashley has worked across therapeutic area disciplines within both the pharmaceutical and CRO industries. With over 11 years’ experience in Clinical Data Management Ashley started his career in the late phase Data Management department at PAREXEL. He progressed into a Data Management operational leadership position where he had overall accountability, as an account lead, for the execution of the Data Management strategy on numerous complex Oncology studies. Ashley joined the Oncology team within the Data Monitoring and Management department at Pfizer in 2018 and is currently an asset lead supporting the development of a number of key, pivotal compounds. Ashley is a business lead for Pfizer’s development and implementation of the Smart Data Query (SDQ) tool, an industry first leveraging AI/ML to hyper-accelerate complex data review and reconciliation activities. Ashley holds a Bachelor of Science degree in Biology from Sheffield Hallam University, UK.

Melissa is currently the Head of Standards and Data Conformity at Pfizer and has over 25 years of experience working in the life sciences industry supporting clinical research in the areas of statistics, statistical reporting and data management, including system implementation and quality management across the biometrics continuum. During this time, she has worked for global CROs, biotechs and large biopharmaceutical companies. Melissa currently leads the Clinical Data Interchange Standards Consortium’s (CDISC) Clinical Data Acquisition Standards Harmonization (CDASH) team and has been an active member since 2006. Ms. Binz has a bachelor’s degree in mathematics from Millersville University and a master’s degree in computer science from Villanova University.